A Resolution recognizing April 26, 2025, as "Diabetic Eye Screening Day" in Pennsylvania.
Summary
House Resolution 113 is a commemorative resolution that recognizes April 26, 2025, as "Diabetic Eye Screening Day" in Pennsylvania. The resolution explains that diabetic retinopathy is a serious complication of diabetes that can damage the retina and is a leading cause of blindness among people with diabetes and working-age adults. It emphasizes that the condition often develops without early symptoms, making regular diabetic eye exams important for early detection and treatment.
The resolution also notes that ophthalmologists across the Commonwealth will host free diabetic eye screenings on that date to address barriers to access and to raise awareness about the importance of routine eye evaluations for people with diabetes. It commends doctors who volunteer their time to provide vision-saving care and encourages public attention to diabetic eye disease and screening.
Impact
HR 113 does not create or amend any statutory law, regulatory program, or funding mechanism. Its legal effect is limited to a formal House recognition of a designated awareness day and a public commendation of participating ophthalmologists. The practical impact is educational and promotional, aimed at encouraging diabetic eye screenings and increasing awareness among people with diabetes, eye-care providers, and the broader public.
Sentiment
The sentiment around the resolution appears strongly supportive and noncontroversial. It advanced through the House Children and Youth Committee by a narrow 14-12 vote, suggesting some committee-level division, but it then passed the House floor overwhelmingly, 200-3. That voting pattern indicates broad bipartisan approval overall, with only limited opposition remaining by final passage.
Contention
The main point of contention appears to have been at the committee stage rather than on the House floor, where the measure was nearly unanimous. Because the resolution is symbolic and health-awareness oriented, any opposition likely reflected general objections to nonbinding resolutions or committee preferences rather than disagreement with the underlying public health message. No substantive policy dispute about diabetic eye disease, screening access, or the recognition itself is evident in the available record.